Fluoroquinolone resistance in non-multidrug-resistant tuberculosis—a surveillance study in New South Wales, Australia, and a review of global resistance rates
Open Access
- 1 September 2014
- journal article
- review article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 26, 149-153
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolonesEuropean Respiratory Journal, 2012
- Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental modelJournal of Antimicrobial Chemotherapy, 2011
- Treatment Outcomes and Survival Based on Drug Resistance Patterns in Multidrug-resistant TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Fluoroquinolone Resistance in Mycobacterium tuberculosis : The Effect of Duration and Timing of Fluoroquinolone ExposureAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trialThe Lancet, 2009
- Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995–2003Journal of Antimicrobial Chemotherapy, 2005
- Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Fluoroquinolone Resistance in Patients with Newly Diagnosed TuberculosisClinical Infectious Diseases, 2003
- American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Outcomes of Patients With Multidrug-Resistant Pulmonary Tuberculosis Treated With Ofloxacin/Levofloxacin-Containing RegimensChest, 2000